Literature DB >> 21903023

Decreased nocturnal oxytocin levels in anorexia nervosa are associated with low bone mineral density and fat mass.

Elizabeth A Lawson1, Daniel A Donoho, Justine I Blum, Erinne M Meenaghan, Madhusmita Misra, David B Herzog, Patrick M Sluss, Karen K Miller, Anne Klibanski.   

Abstract

OBJECTIVE: Anorexia nervosa is characterized by self-induced starvation and associated with severe bone and fat loss. Oxytocin is a peptide hormone involved in appetite and energy homeostasis. Recent data show that oxytocin has an anabolic effect on bone and stimulates osteoblast function. There is limited information about oxytocin levels or their relationship to decreased bone mineral density in anorexia nervosa. Our objective was to investigate the relationship between oxytocin levels, bone mineral density, and body composition in women with anorexia nervosa.
METHOD: We studied 36 women, mean ± SEM age 27.6 ± 1.3 years: 17 with DSM-IV anorexia nervosa and 19 healthy controls in a cross-sectional study. Oxytocin levels were determined from pooled serum samples obtained every 20 minutes from 8 pm to 8 am during an inpatient overnight visit. Fasting leptin levels were measured. Bone mineral density at the anterior-posterior and lateral spine and hip and body composition were assessed by dual energy x-ray absorptiometry. The study was conducted from September 2004 to June 2008.
RESULTS: Subjects with anorexia nervosa versus healthy controls had lower mean ± SEM oxytocin levels (14.3 ± 1.5 vs 31.8 ± 5.1 pg/mL, P = .003), leptin levels (2.7 ± 0.5 vs 11.4 ± 1.1 ng/mL, P < .0001), bone mineral density (anterior-posterior spine: 0.83 ± 0.02 vs 1.04 ± 0.03; lateral spine: 0.63 ± 0.02 vs 0.81 ± 0.02; total hip: 0.79 ± 0.03 vs 0.97 ± 0.03 g/cm², P < .0001), and fat mass (8.8 ± 0.6 vs 19.7 ± 0.9 kg, P < .0001). Oxytocin levels were associated with bone mineral density at the anterior-posterior (r = 0.40, P = .02) and lateral (r = 0.36, P = .04) spine, fat mass (r = 0.42, P = .01), and leptin levels (r = 0.55, P = .001).
CONCLUSIONS: Overnight secretion of oxytocin in women with anorexia nervosa is decreased compared with healthy women. Low oxytocin levels are associated with decreased bone mineral density and body fat and may contribute to anorexia nervosa-induced bone loss. © Copyright 2011 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21903023      PMCID: PMC3731046          DOI: 10.4088/JCP.10m06617

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  33 in total

1.  Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition.

Authors:  R B Mazess; H S Barden; J P Bisek; J Hanson
Journal:  Am J Clin Nutr       Date:  1990-06       Impact factor: 7.045

2.  Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus.

Authors:  M L Hâkansson; H Brown; N Ghilardi; R C Skoda; B Meister
Journal:  J Neurosci       Date:  1998-01-01       Impact factor: 6.167

3.  Severity of osteopenia in estrogen-deficient women with anorexia nervosa and hypothalamic amenorrhea.

Authors:  S Grinspoon; K Miller; C Coyle; J Krempin; C Armstrong; S Pitts; D Herzog; A Klibanski
Journal:  J Clin Endocrinol Metab       Date:  1999-06       Impact factor: 5.958

4.  Postnatal oxytocin injections cause sustained weight gain and increased nociceptive thresholds in male and female rats.

Authors:  K Uvnäs-Moberg; P Alster; M Petersson; A Sohlström; E Björkstrand
Journal:  Pediatr Res       Date:  1998-03       Impact factor: 3.756

5.  Functional oxytocin receptors discovered in human osteoblasts.

Authors:  J A Copland; K L Ives; D J Simmons; M S Soloff
Journal:  Endocrinology       Date:  1999-09       Impact factor: 4.736

6.  CSF oxytocin in anorexia nervosa and bulimia nervosa: clinical and pathophysiologic considerations.

Authors:  M A Demitrack; M D Lesem; S J Listwak; H A Brandt; D C Jimerson; P W Gold
Journal:  Am J Psychiatry       Date:  1990-07       Impact factor: 18.112

7.  Effect of estrogen or insulin-induced hypoglycemia on plasma oxytocin levels in bulimia and anorexia nervosa.

Authors:  P Chiodera; R Volpi; L Capretti; C Marchesi; L d'Amato; A De Ferri; L Bianconi; V Coiro
Journal:  Metabolism       Date:  1991-11       Impact factor: 8.694

8.  The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa.

Authors:  A Klibanski; B M Biller; D A Schoenfeld; D B Herzog; V C Saxe
Journal:  J Clin Endocrinol Metab       Date:  1995-03       Impact factor: 5.958

9.  Central oxytocin increases food intake and daily weight gain in rats.

Authors:  E Björkstrand; K Uvnäs-Moberg
Journal:  Physiol Behav       Date:  1996 Apr-May

10.  Dissociation of oxytocin effects on body weight in two variants of female Sprague-Dawley rats.

Authors:  K Uvnäs-Moberg; P Alster; M Petersson
Journal:  Integr Physiol Behav Sci       Date:  1996 Jan-Mar
View more
  53 in total

Review 1.  State of the art systematic review of bone disease in anorexia nervosa.

Authors:  Madhusmita Misra; Neville H Golden; Debra K Katzman
Journal:  Int J Eat Disord       Date:  2015-08-27       Impact factor: 4.861

2.  Comparison of hip geometry, strength, and estimated fracture risk in women with anorexia nervosa and overweight/obese women.

Authors:  Katherine Neubecker Bachmann; Pouneh K Fazeli; Elizabeth A Lawson; Brian M Russell; Ariana D Riccio; Erinne Meenaghan; Anu V Gerweck; Kamryn Eddy; Tara Holmes; Mark Goldstein; Thomas Weigel; Seda Ebrahimi; Diane Mickley; Suzanne Gleysteen; Miriam A Bredella; Anne Klibanski; Karen K Miller
Journal:  J Clin Endocrinol Metab       Date:  2014-12       Impact factor: 5.958

3.  Cortisol Measures Across the Weight Spectrum.

Authors:  Melanie Schorr; Elizabeth A Lawson; Laura E Dichtel; Anne Klibanski; Karen K Miller
Journal:  J Clin Endocrinol Metab       Date:  2015-07-14       Impact factor: 5.958

Review 4.  The endocrine manifestations of anorexia nervosa: mechanisms and management.

Authors:  Melanie Schorr; Karen K Miller
Journal:  Nat Rev Endocrinol       Date:  2016-11-04       Impact factor: 43.330

5.  Low Fasting Oxytocin Levels Are Associated With Psychopathology in Anorexia Nervosa in Partial Recovery.

Authors:  Yuliya Afinogenova; Cindy Schmelkin; Franziska Plessow; Jennifer J Thomas; Reitumetse Pulumo; Nadia Micali; Karen K Miller; Kamryn T Eddy; Elizabeth A Lawson
Journal:  J Clin Psychiatry       Date:  2016-11       Impact factor: 4.384

Review 6.  Endocrine consequences of anorexia nervosa.

Authors:  Madhusmita Misra; Anne Klibanski
Journal:  Lancet Diabetes Endocrinol       Date:  2014-04-02       Impact factor: 32.069

7.  Leptin secretory dynamics and associated disordered eating psychopathology across the weight spectrum.

Authors:  Charumathi Baskaran; Kamryn T Eddy; Karen K Miller; Erinne Meenaghan; Madhusmita Misra; Elizabeth A Lawson
Journal:  Eur J Endocrinol       Date:  2016-04       Impact factor: 6.664

8.  Bone density, body composition, and psychopathology of anorexia nervosa spectrum disorders in DSM-IV vs DSM-5.

Authors:  Melanie Schorr; Jennifer J Thomas; Kamryn T Eddy; Laura E Dichtel; Elizabeth A Lawson; Erinne Meenaghan; Margaret Lederfine Paskal; Pouneh K Fazeli; Alexander T Faje; Madhusmita Misra; Anne Klibanski; Karen K Miller
Journal:  Int J Eat Disord       Date:  2016-08-16       Impact factor: 4.861

9.  Nocturnal oxytocin secretion is lower in amenorrheic athletes than nonathletes and associated with bone microarchitecture and finite element analysis parameters.

Authors:  Elizabeth A Lawson; Kathryn E Ackerman; Nara Mendes Estella; Gabriela Guereca; Lisa Pierce; Patrick M Sluss; Mary L Bouxsein; Anne Klibanski; Madhusmita Misra
Journal:  Eur J Endocrinol       Date:  2013-02-20       Impact factor: 6.664

10.  Appetite regulatory hormones in women with anorexia nervosa: binge-eating/purging versus restricting type.

Authors:  Kamryn T Eddy; Elizabeth A Lawson; Christina Meade; Erinne Meenaghan; Sarah E Horton; Madhusmita Misra; Anne Klibanski; Karen K Miller
Journal:  J Clin Psychiatry       Date:  2015-01       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.